Appreciate Holdings, Inc. Class A Common Stock

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 231.6% to $2.8190 after the company announced it entered into a term sheet to license the global rights of CNS drugs with the indications of MDD and ADHD to AiBtl BioPharma at the valuation of $667 million. PaxMedica, Inc. (NASDAQ: PXMD) gained 77.8% to $0.3074. PaxMedica reported the completion of a type-B meeting with the FDA. NextPlay Technologies, Inc. (NASDAQ: NXTP) shares surged 36.3% to $0.6250 after falling 21% on Wednesday. NextPlay Technologies received a notice from Nasdaq regarding delayed second-quarter report. Mustang Bio, Inc. (NASDAQ: MBIO) gained 33% to $2.1009. Mustang Bio announced FDA acceptance of IND application for MB-109, a novel combination of MB-101 and MB-108, for the treatment of recurrent glioblastoma and high-grade astrocytoma. Mullen Automotive, Inc. (NASDAQ: MULN) jumped 31.6% to $0.3450. Mullen received favorable decision from Nasdaq Hearings Panel. Impinj, Inc. (NASDAQ: PI) gained 31% to $65.06 after the company reported better-than-expected third-quarter revenue results. The Singing Machine Company, Inc. (NASDAQ: MICS) gained 30% to $0.91. Meta Materials Inc. (NASDAQ: MMAT) rose 28.6% to $0.1662. Appreciate Holdings, Inc. (NASDAQ: SFR) shares climbed 26.8% to $0.1530 after falling around 19% on Wednesday. Appreciate Holdings received a notice from Nasdaq regarding delisting. La Rosa Holdings Corp. (NASDAQ: LRHC) gained 25% to $1.9499. La Rosa launched its proprietary AI technology system 'JAEME' to support real estate agents. Twin Ridge Capital Acquisition Corp. (NYSE: TRCA) rose 24% to $9.27. Bel Fuse Inc. (NASDAQ: BELFB) jumped 23.4% to $48.61 after the company reported third-quarter financial results. reAlpha Tech Corp. (NASDAQ: AIRE) gained 22.8% to $74.44. Endeavor Group Holdings, Inc. (NYSE: EDR) rose 22.2% to $21.65 after the company announced a review of strategic alternatives. Jaguar Global Growth Corporation I (NASDAQ: JGGC) shares climbed 21.7% to $8.01 after gaining over 18% on Wednesday. ImmunityBio, Inc. (NASDAQ: IBRX) gained 21.7% to $1.92. The FDA accepted ImmunityBio's resubmission of its Biologics License Application for N-803 as complete. First Foundation Inc. (NYSE: FFWM) rose 20.7% to $5.91 following upbeat quarterly results. ProSomnus, Inc. (NASDAQ: OSA) gained 19.7% to $0.7185. Blueprint Medicines Corporation (NASDAQ: BPMC) gained 19.4% to $52.49 following strong quarterly results. Green Giant Inc. (NASDAQ: GGE) rose 17.6% to $0.7876 after dipping 14% on Wednesday. Sunnova Energy International Inc. (NYSE: NOVA) jumped 17.3% to $9.40 following third-quarter results. NETGEAR, Inc. ...

Related tickers: OSA, BKYI, THTX, HOG, MGRX, IMCC, PXMD, HTZ, LRHC, PI, ALGN, NVVE, MAT, AIRE, FFWM, BELFB, IBRX, MPW, BETS, CMCSA, MMAT, OII, SAH, BPMC, HCSG, RNAZ, SDA, SFR, HSII, NXTP, VMI, ABVC, MORN, SGHT, WDC, TTD, NOVA, LMDX, WHR, SNOA, NTGR, CGTX, WST, TRCA, SILC, XPRO, WTW, LIPO, SLP, MULN, WU, MBIO, CLS, SWVL, MXL, OPRA, EDR, JGGC, GGE, META, FCN, MICS, AKLI, CANO, BHAT, HAS.

U.S. stocks traded mixed this morning, following the release of several economic reports. Following the market opening Thursday, the Dow traded up 0.10% to 33,069.66 while the NASDAQ fell 0.24% to 12,790.71. The S&P 500 also fell, dropping, 0.13% to 4,181.15. Check This Out: Meta To Rally Over 42%? Here Are 10 Top Analyst Forecasts For Thursday   Leading and Lagging Sectors   Real estate shares rose by 1% on Thursday. In trading on Thursday, communication services shares dipped by 2%.   Top Headline   Bristol Myers Squibb & Co (NYSE: BMY) reported better-than-expected earnings for its third quarter. Bristol Myers Squibb said revenues came in at $10.966 billion, due to lower sales of Revlimid, partially offset by in-line products and its new product portfolio. Analysts were expecting sales of $10.965 billion. Adjusted EPS rose 1% year-over-year to $2.00, beating the consensus of $1.76.   Equities Trading UP   ABVC BioPharma, Inc. (NASDAQ: ABVC) shares shot up 220% to $2.72 after the company announced it entered into a term sheet to license the global rights of CNS drugs with the indications of MDD and ADHD to AiBtl BioPharma at the valuation of $667 million. Shares of PaxMedica, Inc. ...

Related tickers: SILC, BMY, BETS, SFR, ABVC, SNOA, PXMD.